When people hear the word "common cold" or "flu", they usually dismiss it as a harmless, everyday illness — something that's ...

GSK is one of the pharma industry's top vaccine producers, giving Affinivax' shot the marketing muscle it will need to challenge Pfizer's Prevnar 13 and Prevnar 20 products – targeting 13 and 20 ...

It's a companion shot to Merck's Vaxneuvance (formerly V114), which covers 15 serotypes and was approved by the FDA last year as a rival to Pfizer's Prevnar 13 and newer Prevnar 20 vaccines, which ...

Tell us what you think – your expectations and concerns.